Sun Pharmaceuticals reported INR24.89B in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.


Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.37B 230M Dec/2024
Bharat Petroleum INR 7.43B 4.64B Mar/2025
Cipla INR 13.12B 792M Jun/2025
Dr.Reddys Laboratories INR 25.65B 10.39B Jun/2025
Jiangsu Hengrui CNY 3.12B 575.34M Jun/2025
Sh Fosun Pharma CNY 3.14B 30.87M Jun/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 14.71B 3.06B Mar/2025